enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
enGene Holdings: A Potential Oncology Entrant
Source link
Similar Posts
Natco Pharma Shares Fall 1% on 7 USFDA Observations
June 20, 2025June 20, 2025 Shares of Natco Pharma Ltd were trading in the red and 1% lower on 20 June after the company received seven Form-483 observations from the US Food and Drug Administration (USFDA). The firm reported the completion of a USFDA inspection at its pharmaceutical division…
GTK – Gentrack Group
Market Announcement Gentrack Group Limited (NZX/ASX: GTK), a leading provider of software solutions for utilities and airports, today released its results for the half-year to 31 March 2023. Results Summary • Revenue: $84.3m – up 47.7% on H1’22 • EBITDA $16.0m – up $14.8m over H1’22 • Statutory NPAT: $7.9m profit v $5.8m loss in…
How to Earn $100 a Day from Cryptocurrency Mining
CryptocurrencyA cryptocurrency is a digital or virtual form of currency that uses cryptography for security. Unlike traditional currencies issued by central banks, cryptocurrencies operate on de… mining remains a viable way to generate daily income, but success requires strategic planning, efficient equipment, and cost management. Investors looking to earn around $100 per day through mining…
